FDA Investigator Jonathan R Campos

Jonathan R Campos has inspections in 8 countries as of 17 Nov 2023. Jonathan R Campos has collaborated with a combinined 5125 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
190
Last Inspection Date:
17 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Germany, Czechia, Canada, France, Romania, Serbia, Australia
Co-Investigator(s):
A Williams, Adree N Anderson, Adrienne Morgan, Alanna Lmussawwir Bias, Alexandra B Pitkin, Alicia M Frees, Alysia C Alger, Amanda S Zorn, Anders W Evenson, Andrea A Branche, Andrew A Hoopes, Annette Melendez, Anthony R Bucks, Ashlee M Ward, Ashley A Mutawakkil, Avery J Dennis, Barbara J White, Barbara L Rogolsky, Bei Y He, Betty K Baxter, Betty Kay Baxter, Bonnie E Pierson, Brent T Hall, Brett R Havranek, Brittany D Phillips, Brittany D Terhar, Bruce E Taylor, Brunilda Torres, Candace S Tucker, Carl J Montgomery, Carmen Y Fisher, Caroline H Le, Catherine R Olguin, Chad W Rice, Charles R Cote, RIC, Chilton L Ng, Chris A Sack, Christine I Shaw, Christine M Parmentier, Christopher A Hairr, Cody D Rickman, Cody J Alley, Collins M Mason, Courtney R Bratina, Cynthia Jim, CSO, Cynthia L Evitt, Cynthia L Gorveatt, Cynthia M Goudeau, Dana D Carter, SR DDS, Dana J Monroe, Danial S Hutchison, Daniel J Lahar, Daniel Pst Laurent, Darrah, David L Miser, Dawn C Olenjack, Deidre R Edwards, Denise L Burosh, Diana K Krepel, Dianna D Wardlow Dotter, Dina K West, Douglas A Campbell, Dr. Abhijit Raha, PhD, Dr. Mark J Seaton, PhD, Dr. Zhou Chen (nmi), MD PhD, Dustin P Tran, Dwight D Ferguson, Dylan Yao, Edward E Lockwood (EEL), Eileen A Liu, Elizabeth D Gonzales, Elizabeth S Howell, Emily A Baldwin, Emily A Green, Eric C Fox, Eric C Nielsen, Eric M Mueller, PharmD, Eric M Padgett, Eric T Huebler, Erika V Butler, Erin C Dugan, Erin M Mcdowell, Erin Mcdowell, Esther A Ofori, Farhana Khan, George Ivan Wey, Ginger M Sykes, Gloria A Milster, Hanna L Potter, Harperd, Hasan A Irier, PhD, Heath W Cartwright, Himanshu Gupta, PhD, Hiwot A Kesi, Huffmanc, Isabel Y Espinosa, Isatu N Bah, Ismael Garibay, Ismael Olvera, IV, Jacob W Reynolds, James D Planchon, James I Giefer, James J Houlihan, James P Mcreavey, Jamie L Dion, Jane E Nelson, Janesa A Licorish, Janet Pulver, Janete A Eaker, Janete A Oliveira, Janna C Hutchinson, Jasjeet K Sekhon, Jeanne J Thai, Jefferey A Hangartner, Jeffery A Hangartner, Jeffrey B Moody, Jeffrey W Shrifter, DPM, Jennifer A Baker, Jessica E Hensley, Jessica L Peterson, Joan T Briones, John A Iwen, John W Banks, Johnson, Johnsont, Jonathan E Campos, Joseph R Lambert, Julie N Vosilus, Justin A Boyd, Jyoti B Patel, PhD, Kaitlyn T Dang, Kara L Roden, Karen C Daugherty, Karen M Cooper, Karen M Montgomery (KMM), Katherine M Taylor, Kathleen B Swat, Kathleen J Close, Kathleen J Klier, Kathleen S Tormey, Kathryn A Bushur, Kellia N Hicks, Kelly D Moore, Kelly D Sheppard, Kethleen J Klier, Kimberley A Hoefen, Kimetha A King, Kristi B Panzer, Kristi Mhampton Thurston, Latonya M Mitchell, Latrice G Jones, Laura B Kennedy, Lavender M Huskey, LCDR Angelica M Chica, LCDR Matthew J Morrison, Linda F Murphy, Linda K Cline, Linda M Cheny, Linda R Kuchenthal, Linhart, Lionell L Thomas, Lisa D Ellis, Lisa L Flores, Lisa L Gilliam, Lori A Gioia, Lori B Wikstrom, Louis S Chen, LT Mark A Chen, MPH, LT Richard A Lyght, Lyndsey G Smith, Makini Cobourne Duval, PhD, Marc A Jackson, Jr, Marcus F Yambot, Marion W Nadeau, Mark E Chan, Mary K Concannon, Matthew A Walburger, Matthew F Duff, Matthew M Vernon, Matthew P Barnard, Matthew P Bernard, Matthew R Dionne, Meisha Waters, Melinda L Rice, Melva J Palmer, Meredith M Cobb, Michael A Feingold, Michael F Skelly, PhD, Michael R Goga, Michael S Kopf, Michele L Obert, Michele Perry Williams, Minerva Rogers, Miranda D Mcdonald, Mitzi A Schwertfeger, Mohsen Rajabi Abhari, FDA, Monica M Mcclure, Nadine J Nanko, Nadine Nanko Johnson, Nancy G Schmidt, Naseem S Jouhari, Nathan R Moon, Ngoc B Kelsch, Nia K Walker, Nicholas Z Lu, Nicole J Clausen, Nicole J Conklin, Nilufer M Tampal, PhD, Paige E Shelborne, Pamela L Vega, Patricia A Brown, Patricia D Stahnke, Patrick L Wisor, Patrick S Price, Paul F Rader, Peter E Gruman, Peter T Regan, Philip E Ake, Rashonda N Rucker, Raymond H Price, Rebecca T Davis, Richard D Coleman, Richard L Rutherford, Ricki A Chase, Rita K Kabaso, Robert J Ham, Robert J Nesselhauf, Robert S Woodruff, Robin E Hayes, Rodney D Combs, Ronda R Loyd Jones, Rose Xu, Rowena S Nguyen, Ruben C Ayala, PharmD, Ruth A Williams, Samson O Oluseye, Samuel K Gibbons, Jr, Sandra A Hughes, Sangeeta M Khurana, PhD, Santiago Gallardo Johnson, Sarah E Morris, Sarah E Rhoades, Savini, Scott A Jepson, Scott B Laufenberg, Shafiq S Ahadi, Shanna R Haden, Shaun M Olson, Shaun M Stracener, Shawn B Johnson, Sheri L Stephenson, Shwnji Susie Lee, Srinivas R Chennamaneni, PhD, Stacey F Rivette, State Agency, Stephanie L Shapley, Stephen T Hansen, Steve P Yost, Steven C Clifford, Steven D Kehoe, Steven P Allen, Stroman, Sunitha K Rajaram, PhD, Susan L Young, Susanna E Ford, Analyst, Susie H Lee, Tamara J Umscheid, Tamara L Setzer, Tara M Aikens, Teena H Aiken, Thai T Duong, Thao T Kwan, Theresa C Klaman, Theressa B Smith, Thomas R Beilke, Thuy T Nguyen, LCDR, Tiara Nbrown Crosen, Timothy C Grome, Timothy D Evans, Tristian E Strait, Veronica Fuentes, MS, Vickie J Kanion, Victoria A Wagoner, Walsworth, Warren J Lopicka, Weston K Szymanski, Xiaohan Cai, PhD, Xikui Chen (nmi), PhD, Yiyue Zhang (nmi), PhD, Zachary A Bogorad, Zachary L Stamm

Jonathan R Campos's Documents

Publish Date Document Type Title
July, 2017 EIR David Miklos, MD - EIR, 2017-07-27
May, 2019 FDA 483 Brian R. Davis, MD - Form 483, 2019-05-16
November, 2018 FDA 483 Frei, Donald MD - Form 483, 2018-11-01
January, 2013 FDA 483 Dyna-Tek Industries - Form 483, 2013-01-24
January, 2020 EIR Lovelace Biomedical Research Institute - EIR, 2020-01-31
August, 2019 EIR Samuel A. Mujica Trenche, MD - EIR, 2019-08-09
February, 2023 FDA 483 Immunity Bio, Inc - Form 483, 2023-02-10
May, 2018 FDA 483 Response PPD Development, L.P. - Form 483R, 2018-06-05
February, 2015 FDA 483 Medical Solutions International Inc - Form 483, 2015-02-20
October, 2015 FDA 483 Remel, Inc - Form 483, 2015-10-23
November, 2019 FDA 483 SCL Health IRB - Form 483, 2019-11-07
March, 2013 EIR Pro-Pet LLC - EIR, 2013-03-01
October, 2015 FDA 483 Response Remel, Inc - Form 483R, 2015-11-06
October, 2015 EIR Remel, Inc - EIR, 2015-10-23
March, 2021 EIR OPKO Health, Inc. - EIR, 2021-03-01
June, 2018 FDA 483 Esoterix Clinical Trials Services - Form 483, 2018-06-27
July, 2021 FDA 483 Veterinary & Biomedical Research Center, Inc. - Form 483, 2021-07-01
July, 2015 FDA 483 Central Solutions Inc - Form 483, 2015-07-10
January, 2020 FDA 483 Response Lovelace Biomedical Research Institute - Form 483R, 2020-02-20
November, 2018 EIR Melamed, Isaac R. , M.D. - EIR, 2018-11-08
July, 2021 FDA 483 Redbeast Enterprises Inc dba High Quality Research - Form 483, 2021-07-29
January, 2018 FDA 483 Frank Dinenno - Form 483, 2018-01-23
January, 2020 FDA 483 Lovelace Biomedical Research Institute - Form 483, 2020-01-31
January, 2013 FDA 483 Apria Healthcare Inc dba Knoll Patient Supply - Form 483, 2013-01-09
July, 2014 EIR Remel, Inc - EIR, 2014-07-03
July, 2021 FDA 483 Response Redbeast Enterprises Inc dba High Quality Research - Form 483R, 2021-07-29
July, 2014 FDA 483 Remel, Inc - Form 483, 2014-07-03
June, 2018 EIR Esoterix Clinical Trials Services - EIR, 2018-06-27
June, 2018 FDA 483 Response Esoterix Clinical Trials Services - Form 483R, 2018-07-11
May, 2018 FDA 483 PPD Development, L.P. - Form 483, 2018-05-18
May, 2018 EIR PPD Development, L.P. - EIR, 2018-05-18
January, 2013 EIR Apria Healthcare Inc dba Knoll Patient Supply - EIR, 2013-01-09
August, 2019 FDA 483 Samuel A. Mujica Trenche, MD - Form 483, 2019-08-09
September, 2015 FDA 483 Psi Health Solutions - Form 483, 2015-09-09
August, 2023 FDA 483 Mimi Liu, MD - Form 483, 2023-08-18
September, 2015 FDA 483 Chalgren Enterprises, Inc. - Form 483, 2015-09-03
July, 2021 EIR Redbeast Enterprises Inc dba High Quality Research - EIR, 2021-07-26

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more